In what clinical context would you consider offering first time catheter ablation for symptomatic atrial fibrillation in patients with advanced heart failure, as opposed to a trial of antiarrhythmics and/or cardioversion?

I would favor first-time catheter ablation in patients with advanced heart failure as a way to improve LVEF%, symptoms, reduce risk for recurrent hospitalizations, and decrease mortality. Many patients with advanced heart failure have an enlarged LAVI, so DCCV will only be a temporary solution and amiodarone and dofetilide are the only AAD options with systolic heart failure. Prior to pursing an ablation, I would optimize the patient to reduce the risk of peri-operative complications. Can be helpful to discuss with their heart failure specialist to determine need for diuresis, right heart catheterization, and medication adjustment. Also, I generally pursue TEE/DCCV along with starting an AAD such as amiodarone to restore and maintain SR for at least a few weeks prior to ablation.

I find that patients feel and do better with ablation +/- AAD post ablation rather than pursuing DCCV +/- AAD without ablation. In patients that prefer not to pursue ablation up front even after discussing risks/benefits, I will perform TEE/DCCV + AAD to determine if their symptoms improve and repeat TTE to see if LVEF% also improves. 

Sohns et al., PMID 37634135

This is strongly supported by the CASTLE-AF trial.